These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17875705

  • 1. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
    Dürig J, Ebeling P, Grabellus F, Sorg UR, Möllmann M, Schütt P, Göthert J, Sellmann L, Seeber S, Flasshove M, Dührsen U, Moritz T.
    Cancer Res; 2007 Sep 15; 67(18):8653-61. PubMed ID: 17875705
    [Abstract] [Full Text] [Related]

  • 2. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A, Marcus H, Dekel B, Shkarchi R, Arditti F, Shvidel L, Shtalrid M, Bucher W, Canaan A, Ergas D, Berrebi A, Reisner Y.
    Cancer Res; 1999 Dec 01; 59(23):5968-74. PubMed ID: 10606243
    [Abstract] [Full Text] [Related]

  • 3. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
    Aydin S, Grabellus F, Eisele L, Möllmann M, Hanoun M, Ebeling P, Moritz T, Carpinteiro A, Nückel H, Sak A, Göthert JR, Dührsen U, Dürig J.
    Eur J Haematol; 2011 Jul 01; 87(1):10-9. PubMed ID: 21692849
    [Abstract] [Full Text] [Related]

  • 4. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 Jul 01; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct 01; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 6. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM, Katato K, Almatchy VP, Wall N, Liu KZ, Schultz CP, Mantsch HH, Varterasian M, al-Katib AM.
    Clin Cancer Res; 1998 Feb 01; 4(2):445-53. PubMed ID: 9516935
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D, Schubert M, Pietsch L, Taubert I, Wuchter P, Eckstein V, Bruckner T, Zoeller M, Ho AD.
    Exp Hematol; 2009 Dec 01; 37(12):1423-34. PubMed ID: 19819294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN, Grabovsky V, Wang W, Desch P, Rubenzer G, Wollner S, Binsky I, Vallon-Eberhard A, Sapoznikov A, Burger M, Shachar I, Haran M, Honczarenko M, Greil R, Alon R.
    Cancer Res; 2009 Apr 01; 69(7):3121-30. PubMed ID: 19293181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
    Yacoub-Youssef H, Marcheix B, Calise D, Thiers JC, Therville N, Benoist H, Blaes N, Ségui B, Dambrin C, Thomsen M.
    Transpl Immunol; 2005 Dec 01; 15(2):157-64. PubMed ID: 16412960
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
    Mohammad RM, Mohamed AN, Hamdan MY, Vo T, Chen B, Katato K, Abubakr YA, Dugan MC, al-Katib A.
    Leukemia; 1996 Jan 01; 10(1):130-7. PubMed ID: 8558918
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.